Volition to host virtual investor event on nu.q® nets, "casting a new light on sepsis management", on february 14, 2025

Henderson, nev. , feb. 5, 2025 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, today announced it will host a virtual investor event on friday, february 14, 2025 at 8:00 am et, featuring volition company management dr. andrew retter, chief medical officer and gael forterre, chief commercial officer.
VNRX Ratings Summary
VNRX Quant Ranking